Drug Topics

OCTOBER 3, 2023

The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.

211

211

Pharmacy Times

OCTOBER 3, 2023

Lack of awareness, cultural beliefs, and physician preferences may influence whether minority patients receive palliative care during metastatic breast cancer treatment.

153

153

Drug Topics

OCTOBER 3, 2023

Despite pleas from celiac disease advocates, the FDA still does not require drug manufacturers to note on the label whether a medication contains gluten.

Labelling 201

Labelling FDA 201

Pharmacy Times

OCTOBER 3, 2023

Although respondents reported no impacts on patient safety, workload significantly increased during the COVID-19 pandemic and led to major burnout challenges.

Communication 149

Communication 149

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

OCTOBER 3, 2023

PBMs, retail chains, and pharmacy schools have all contributed to the current state of the profession. It's time they worked on fixing it.

187

187

Pharmacy Times

OCTOBER 3, 2023

The new report includes actions to implement that could improve workplace conditions, which are the leading causes of high stress and occupational burnout across the pharmacy profession.

139

139

Pharmacy Times

OCTOBER 3, 2023

Similarly, the results of a survey by the National Foundation for Infectious Diseases demonstrated that approximately 23% were worried about COVID-19 and 19% for respiratory syncytial virus.

132

132

STAT

OCTOBER 3, 2023

WASHINGTON — It started with a tweet: A year-old, 43-second clip of Kevin Wang talking about how parents and teachers can help affirm and support a child’s gender identity, encouraging children to explore. The vitriolic tweets were swift, and they snowballed. Right-wing influencers accused Wang, an unassuming Seattle physician, of “mutilating” and “destroying” children, though he did not discuss surgery in the clip.

Hospitals 145

Hospitals 145

Fierce Healthcare

OCTOBER 3, 2023

About 8 in 10 women say they are delaying care until their symptoms worsen or affect their daily lives, and 43% have recently missed a day or more of work due to health issues. | About 8 in 10 women say they are delaying care until their symptoms worsen or affect their daily lives, and 43% have recently missed a day or more of work due to health issues.

132

132

STAT

OCTOBER 3, 2023

In the latest battle over access to medicines, Colombian authorities have decided to issue a compulsory license for a needed HIV treatment, a step that underscores ongoing friction between the pharmaceutical industry and cash-strapped governments around the world. By issuing such a license, the Colombian government hopes to obtain lower-cost generic versions of an HIV medicine called dolutegravir, which is made by ViiV Healthcare, a company that specializes in HIV treatments and is largely contr

142

142

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

OCTOBER 3, 2023

Not only did enterococci promote C. difficile pathogenesis, but it was also shown to provide fermentable amino acids, facilitating its virulence agitated gastrointestinal tracts.

123

123

Fierce Pharma

OCTOBER 3, 2023

As Galderma attempts to round out its injectable aesthetics portfolio with approvals to resolve crow’s feet and frown lines, the FDA spotted a few manufacturing wrinkles in its RelabotulinumtoxinA | The agency spotted issues relating to chemistry, manufacturing and controls (CMC) processes in the company's application for its liquid botulinum toxin type A.

FDA 126

FDA 126

Pharmacy Times

OCTOBER 3, 2023

It is vital for health care teams to recognize the signs and symptoms of antiphospholipid syndrome and to identify the severity of a patient’s diagnosis based on their aPL profile.

121

121

The Checkup by Singlecare

OCTOBER 3, 2023

Dealing with anxiety can often feel lonely, but the reality is that anxiety is a very common mental health condition. According to the National Institutes of Health (NIH), about 19% of American adults experienced an anxiety disorder in the past year. There are varying types and severities of anxiety disorders, many of which are characterized by repeated instances of intense fear or panic.

Mayo Clinic 124

Mayo Clinic 124

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

OCTOBER 3, 2023

NVX-CoV2601 vaccine adjuvanted 2023-2024 formula granted EUA for the prevention of COVID-19 in those 12 years of age and older.

Vaccines 145

Vaccines FDA 145

STAT

OCTOBER 3, 2023

As theorists from Samuel Coleridge to Kenneth Burke have noted, language often does our thinking for us. In health care, all too often, that leads to problems. In a particularly worrisome example of this, recent headlines about the new monoclonal antibody injection nirsevimab (trade named Beyfortus) designed to protect infants against the third culprit in last year’s tripledemic — respiratory syncytial virus (RSV) — contain language that may cloud parents’ d

123

123

Drug Topics

OCTOBER 3, 2023

Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.

FDA 98

FDA 98

Fierce Healthcare

OCTOBER 3, 2023

When it comes to kidney disease, the numbers speak for themselves: 130,000 Americans are diagnosed with chronic kidney disease each year, and one in three adults is at risk of developing the diseas | Amidst these challenges, the Centers for Medicare and Medicaid Services has proposed policies that will undermine the individuals they seek to serve – those living with kidney failure.

121

121

STAT

OCTOBER 3, 2023

LONDON — Three scientists whose work on electrons widened the world’s understanding of the particles’ behavior inside atoms and molecules won the 2023 Nobel Prize in physics on Tuesday.   In health care, their research is being applied to improve diagnostics, with the potential to create tests that can detect minute changes in the level of molecules in the blood.

120

120

Fierce Healthcare

OCTOBER 3, 2023

More than 75,000 Kaiser Permanente workers are poised to launch a strike Wednesday that organizers are describing as “the largest healthcare worker strike in U.S. history.” | A Tuesday statement from participating unions showed no signs of slowing down. The large nonprofit provider and insurer, which said it hopes for final-day deal, plans to keep hospitals and EDs open should the three-day demonstration become a reality.

Insurance 121

Insurance Hospitals 121

Fierce Pharma

OCTOBER 3, 2023

Four months after GSK settled a key case in California over its heartburn medication Zantac, AstraZeneca is following suit, agreeing to resolve personal injury claims over its heartburn drugs Nexiu | Four months after GSK settled a key case in California over its heartburn medication Zantac, AstraZeneca is following suit, agreeing to resolve personal injury claims over its heartburn drugs Nexium and Prilosec.

118

118

Fierce Healthcare

OCTOBER 3, 2023

Insurtech Alignment Health is teaming up with grocery delivery company Instacart to roll out co-branded Medicare Advantage (MA) plans next year in 13 California and Nevada counties.

118

118

Fierce Pharma

OCTOBER 3, 2023

After a confirmatory trial flop this past summer, Takeda is calling it quits on its targeted non-small cell lung cancer (NSCLC) drug Exkivity. | Takeda will work with the FDA to chart a voluntary withdrawal of Exkivity in the U.S., where the drug is approved for certain adult lung cancer patients whose disease has progressed on or after platinum-based chemotherapy.

Chemotherapy 110

Chemotherapy FDA 110

Fierce Healthcare

OCTOBER 3, 2023

I know several colleagues who, like me, trained to be doctors but they later pivoted to take on largely administrative roles working for health plans. | Health plans rely on their own guidelines, or those licensed from third parties, which have been designed to help them control costs. They do not always agree with guidelines that were designed to be used directly by healthcare professionals.

115

115

STAT

OCTOBER 3, 2023

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market. The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS.

FDA 110

FDA 110

Fierce Pharma

OCTOBER 3, 2023

As an FDA advisory committee gears up to discuss the data supporting Amgen’s Lumakras, a pre-meeting briefing document from the agency suggests the KRAS inhibitor might have a tough road ahead. | An FDA advisory committee is set to determine if the trial was adequate and well-controlled as the agency weighs a potential full approval for Amgen's KRAS inhibitor.

FDA 109

FDA Documentation 109

STAT

OCTOBER 3, 2023

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money. Eli Lilly agreed to purchase Point Therapeutics Tuesday morning for $1.4 billion , a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter.

108

108

pharmaphorum

OCTOBER 3, 2023

How the rise of medical device use in pharma R&D is driving wearable technology in healthcare and revolutionising the medical industry Mike.

121

121

The Checkup by Singlecare

OCTOBER 3, 2023

Adequate water intake can impact the entire body. Brain function, muscles, organs, waste removal, and skin elasticity are all affected by the amount of water an individual consumes. In addition, water helps regulate body temperature and majorly contributes to the absorption of vitamins and nutrients as part of the digestive process. Weight loss is another important benefit of drinking water.

Immunization 105

Immunization 105

Drug Store News

OCTOBER 3, 2023

According to a Bloomberg report, Neal Sample, a consultant and former CIO at Northwestern Mutual, will reportedly help interim CEO Ginger Graham make decisions about new tech initiatives.

105

105

European Pharmaceutical Review

OCTOBER 3, 2023

A paper published in Regulatory Toxicology and Pharmacology has proposed a consistent, health protective read-across methodology for extractables and leachables (E&Ls). The Extractables Leachables Safety Information Exchange (ELSIE) ’s safety team developed the methodology for generating permitted daily exposures (PDEs) for E&Ls. Current challenges in extractables and leachable studies According to the paper, a challenge for E&L read-across is that most toxicology data is from the or

Compounding 100

Compounding Pharmaceutical Companies Pharmaceutical Companies 100

Drug Store News

OCTOBER 3, 2023

Throughout October, for every CVS Health brand period product purchased, the retailer will donate two to communities in need through a partnership with Feeding America.

105

105

The Checkup by Singlecare

OCTOBER 3, 2023

Compare aspirin alternatives | Other oral NSAIDs | COX-2 Inhibitors | Topical NSAIDs | Tylenol | Platelet inhibitors | Natural alternatives | How to switch meds Aspirin is an inhibitor of thromboxane A2 (TXA2) and prostacyclin (PGI-2), and this action is responsible for vascular smooth muscle relaxation, vasodilation, and decreasing platelet aggregation ( blood clots ).

Dosage 98

Dosage Insurance 98

Drug Store News

OCTOBER 3, 2023

Kroger Mercado's expansive assortment now offers more than 50 products, including items such as fresh meat, beverages, snacks, sides, desserts and more.

110

110